These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9098740)

  • 1. Role of phospholipase A2 in mast cell activation.
    Varsani M; Pearce FL
    Inflamm Res; 1997 Mar; 46 Suppl 1():S9-10. PubMed ID: 9098740
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of secretory phospholipase A2 enzymes on mast cells of rat, guinea pig and human.
    Lau HY; Roche CM
    Inflamm Res; 1997 Mar; 46 Suppl 1():S19-20. PubMed ID: 9098745
    [No Abstract]   [Full Text] [Related]  

  • 3. Extracellular phospholipase A2 and histamine release from rat peritoneal mast cells.
    Nagai H; Sakamoto T; Kondo M; Miura T; Inagaki N; Koda A
    Int Arch Allergy Appl Immunol; 1991; 96(4):311-6. PubMed ID: 1725674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of phospholipase A2 inhibitor on substance P-induced histamine release from rat peritoneal mast cells].
    Hisada T; Ishizuka T; Kurosawa M
    Arerugi; 1991 May; 40(5):555-8. PubMed ID: 1715683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of secretory PLA2 on rat peritoneal mast cells activated by different secretagogues.
    Lau HY; Roche CM
    Adv Exp Med Biol; 1997; 407():105-8. PubMed ID: 9321939
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of histamine secretion from rat peritoneal mast cells and rabbit leukocytes by p-bromophenacyl bromide, a phospholipase A2 inhibitor.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Res Commun Chem Pathol Pharmacol; 1987 Jan; 55(1):17-24. PubMed ID: 2436269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phospholipase A2 inhibitor ONO-RS-082 on substance P-induced histamine release from rat peritoneal mast cells.
    Kurosawa M; Hisada T; Ishizuka T
    Int Arch Allergy Immunol; 1992; 97(3):226-8. PubMed ID: 1375204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of type I and type II phospholipase A2 on rat peritoneal mast cells.
    Roche CM; Lau HY; Jones RL; Lai CK
    Inflamm Res; 1995 Apr; 44 Suppl 1():S5-6. PubMed ID: 8520997
    [No Abstract]   [Full Text] [Related]  

  • 9. Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms.
    Lloret S; Moreno JJ
    Toxicon; 1993 Aug; 31(8):949-56. PubMed ID: 8212047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.
    Damerau B; Lege L; Oldigs HD; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(2):141-56. PubMed ID: 49854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities.
    Landucci EC; Castro RC; Pereira MF; Cintra AC; Giglio JR; Marangoni S; Oliveira B; Cirino G; Antunes E; De Nucci G
    Eur J Pharmacol; 1998 Feb; 343(2-3):257-63. PubMed ID: 9570475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of platelet activating factor antagonists on the protamine sulphate stimulated release of histamine from peritoneal mast cells of rats in vitro.
    Lohde C; Bahr T; Labes D; Grupe R
    Arzneimittelforschung; 1992 Jan; 42(1):27-31. PubMed ID: 1375025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group II phospholipase A2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells.
    Murakami M; Kudo I; Fujimori Y; Suga H; Inoue K
    Biochem Biophys Res Commun; 1991 Dec; 181(2):714-21. PubMed ID: 1721808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat paw oedema and mast cell degranulation caused by two phospholipase A2 enzymes isolated from Trimeresurus mucrosquamatus venom.
    Wang JP; Teng CM
    J Pharm Pharmacol; 1990 Dec; 42(12):846-50. PubMed ID: 1713267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2.
    Murakami M; Kudo I; Inoue K
    FEBS Lett; 1991 Dec; 294(3):247-51. PubMed ID: 1756867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of adenosine and its analogues on histamine release from mast cells.
    Dexter EJ; Butchers PR; Reeves JJ; Sheehan MJ; Pearce FL
    Inflamm Res; 1999 Apr; 48 Suppl 1():S7-8. PubMed ID: 10350137
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysophosphatidylserine enhances exogenous type II phospholipase A2-induced activation of rat serosal mast cells.
    Hara N; Murakami M; Inoue K; Kudo I
    Biol Pharm Bull; 1996 Mar; 19(3):474-6. PubMed ID: 8924921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of calmodulin and chlorpromazine on the activity of phospholipases A2 from various sources].
    Azizova NN; Muratova UZ; Gagel'gans AI; Saatov TS
    Biokhimiia; 1990 Jan; 55(1):23-8. PubMed ID: 2344456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histamine agonists and antagonists on rat peritoneal mast cells.
    Stenton GR; Lau HY
    Inflamm Res; 1997 Mar; 46 Suppl 1():S15-6. PubMed ID: 9098743
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of deoxycholic acid-induced histamine release from mast cells of guinea-pig rectocolonic mucosa and rat peritoneal cavity.
    Peh KH; Wan BY; Assem ES
    Agents Actions; 1991 May; 33(1-2):76-80. PubMed ID: 1716841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.